• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Catalog Number 7510600
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dysphagia/ Odynophagia (1815); Inflammation (1932); Nerve Damage (1979); Neuropathy (1983); Pain (1994); Respiratory Distress (2045); Weakness (2145); Osteolysis (2377); Patient Problem/Medical Problem (2688); No Code Available (3191)
Event Type  Injury  
Event Description
It was reported that the patient underwent a posterior lumbar interbody fusion and an anterior lumbar interbody fusion surgery using rhbmp-2/acs with a metal cage.The patient's post-operative period was marked by severe pain.Following the surgery, the patient suffered from autonomic neuropathy, small fiber neuropathy, peripheral neuropathy, muscle atrophy and nerve damage, inflammatory reactions, chronic radiculitis, retrograde ejaculation, osteolysis (bone resorption), displacement or migration of the spacer cage, pseudoarthrosis, dysphagia, difficulty breathing, difficulty gripping and holding items, and chronic pain.The patient now suffers from severe injuries and damages, including bone overgrowth causing nerve compression, chronic pain and radiculitis.
 
Manufacturer Narrative
(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Products from multiple manufacturers were implanted during the procedure.Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that on (b)(6) 2006: the patient was pre-operatively diagnosed with: internal disc disruption and degenerative disc disease l5-s1; spinal stenosis l5-s1; low back pain and lower extremity radiculopathy and underwent the following procedures: radical wide extensive total and complete discectomy at the l5-s1 level with complete removal of disk; complete removal of cartilaginous end plates; bony end plate contouring and central canal decompression; anterior inter body fusion (arthrodesis) at the l5-s1 level; anterior segmental titanium instrumentation at the l5-s1 level using four-hole titanium plate and locking screw system; use of lt threaded titanium cage measuring 14 mm in height: 23 mm in length at the l5-s1 level on right; this functions as a biomechanical device for the intervertebral defect for the l5-s1 level on right; use of lt threaded titanium cage measuring 14 mm in height, 23 mm in length at the l5-s1 level on the left; this functions as a biomechanical device for the intervertebral defect for the l5-s1 level on left.As per op-notes, ¿a cage lt threaded titanium cage measuring 14 mm in height and 23 mm in length¿was placed at l5-s1 on the right¿the cage measuring 14 mm in height and 23 mm in length was placed at l5-s1 on left.We then used bone morphogenic protein soaked in collagenous sponges.This was placed within the cages as well as the interstices around the cage and our inter body fusion and arthrodesis at the l5-s1 level was completed.Fluoroscopy, ap, lateral, and oblique planes demonstrate acceptable position, alignment, instrumentation and construct placed.The patient tolerated the procedure well without intraoperative complication.¿.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer Contact
huzefa mamoola
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key3659392
MDR Text Key4284968
Report Number1030489-2014-00718
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,consumer
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup
Report Date 06/14/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number7510600
Device Lot NumberM115004AAH
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 02/04/2014
Initial Date FDA Received03/05/2014
Supplement Dates Manufacturer ReceivedNot provided
06/14/2016
Supplement Dates FDA Received07/11/2016
09/23/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age36 YR
-
-